Board Member: David Egilman, MD
1. Expert witness David Egilman wins billions—and makes enemies—as he fights companies over public health, Science Magazine 2019
2. Court Records Show How a Medical Device ‘Seeding Trial’ Disguised Marketing as Science Health News Review,2018
3. J&J seeks retraction of paper critical of Pinnacle hip study
4. Grave fraudulence in medical device research: a narrative review of the PIN seeding study for the Pinnacle hip system, Accountability in Research 2018; Joan E. Steffen, B.A., Ella A. Fassler, B.S., Kevin J. Reardon, M.A., & David S. Egilman, M.D., M.P.H.
5. Artificial Hip Maker Demands Retraction Of A Paper Calling Its Research ‘Grave Fraudulence’ STAT News 2018
6. Corporate Corruption of Science—Another Asbestos Example, American Journal of Industrial Medicine
7. Sudden Shift at a Public Health Journal Leaves Scientists Feeling Censored ProPublica
8. ‘YOU WANT A DESCRIPTION OF HELL?’ OXYCONTIN’S 12-HOUR PROBLEM, Los Angeles Times, 2016 Excerpt: For a brief moment three years ago, it seemed the problems with 12-hour dosing might get wider attention. The FDA had called for public input on how to make painkiller labels safer. Dr. David Egilman, a Brown University professor of family medicine who had served as a plaintiff’s expert in unsuccessful suits against Purdue, saw it as an opportunity to alert agency officials to problems with OxyContin’s 12-hour claim.
